ADVANCED OR METASTATIC NON-SMALL-CELL LUNG CANCER
Clinical trials for ADVANCED OR METASTATIC NON-SMALL-CELL LUNG CANCER explained in plain language.
Never miss a new study
Get alerted when new ADVANCED OR METASTATIC NON-SMALL-CELL LUNG CANCER trials appear
Sign up with your email to follow new studies for ADVANCED OR METASTATIC NON-SMALL-CELL LUNG CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New combo shows promise in Tough-to-Treat lung cancer
Disease control OngoingThis study tests a new combination of two drugs (ceralasertib and durvalumab) against standard chemotherapy (docetaxel) in people with advanced non-small cell lung cancer that has worsened after prior treatments. About 594 participants will be enrolled to see if the combo helps t…
Matched conditions: ADVANCED OR METASTATIC NON-SMALL-CELL LUNG CANCER
Phase: PHASE3 • Sponsor: AstraZeneca • Aim: Disease control
Last updated May 26, 2026 10:48 UTC
-
Lung cancer shot: new Under-the-Skin drug combo aims to simplify treatment
Disease control OngoingThis study tests whether a new under-the-skin (subcutaneous) version of amivantamab, given with lazertinib, works as well as the standard intravenous (IV) version in people with advanced EGFR-mutated non-small cell lung cancer that has worsened after prior treatments. About 418 p…
Matched conditions: ADVANCED OR METASTATIC NON-SMALL-CELL LUNG CANCER
Phase: PHASE3 • Sponsor: Janssen Research & Development, LLC • Aim: Disease control
Last updated May 20, 2026 12:00 UTC